Nimesulide ban: Govt bars sale of oral painkiller doses above 100 mg
The government has barred the manufacture and sale of oral nimesulide formulations above 100 mg, saying higher doses carry health risks and safer options are available.
The government has barred the manufacture and sale of oral nimesulide formulations above 100 mg, saying higher doses carry health risks and safer options are available.
The Union Health Ministry, in partnership with the World Health Organisation, rolled out a month-long Delhi Metro campaign on women’s and girls’ health and well-being at the Sultanpur Metro Station here on Wednesday.
The facilities will be open to the public from November 14 until the close of the 44th India International Trade Fair (IITF) in New Delhi on November 27.
During the meeting, participants deliberated on policy priorities such as equitable workforce distribution, quality assurance in education and training institutions, leadership development, and career progression opportunities for nursing professionals.
She urged mass public participation for the ongoing nationwide awareness drive until October 17, stating that nearly 70 percent of deaths due to heart failure occur outside the hospital settings — where immediate medical assistance is often unavailable.
With the addition of the new cases, the overall caseload in the country rose to 4,50,12,431. Among these, also included the JN.1 Covid variant cases.
According to data from the Health Ministry, the death toll rose to 5,33,332 as four more succumbed to the disease.
Notably, the ministry had eased the COVID-19 guidelines for international travelers and dropped earlier requirements for RT-PCR based testing of a random two per cent subset of travelers coming to India in the month of July.
In the health camps held till November 26, more than 9,35,970 Ayushman cards were created and over 1,07,000 physical cards were distributed.
It said there is a low risk to India from both the avian influenza as well as the clusters of respiratory illness reported in China.
